Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Upconversion-luminescent nanomaterials for biomedical applications

Authors
Rafique, RafiaKailasa, Suresh KumarPark, Tae Jung
Issue Date
2021
Publisher
Elsevier
Keywords
Bioimaging; Chemotherapy; Photodynamic therapy; Photothermal therapy; Upconversion
Citation
Upconversion Nanophosphors, pp 337 - 374
Pages
38
Journal Title
Upconversion Nanophosphors
Start Page
337
End Page
374
URI
https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/55687
DOI
10.1016/B978-0-12-822842-5.00005-4
ISSN
0000-0000
Abstract
Upconversion nanoparticles (UCNs) have been attracted considerable research interest because of their unique merits, which are outstanding optical merits: sharp emissions, significant anti-Stokes shifts, long lifetimes, and negligible photobleaching in biomedical fields. In this chapter, the recent efforts on the fabrication of UCNs with organic, inorganic, and biomolecules that create UCNs as the next generation biomedical agents for drug-delivery, bioimaging, and cancer therapy were illustrated. The recent developments and uses of UCNs in analytical and biomedical research areas were described with their optical properties and the surface modifications of UCNs and their synergistic theranostic applications including photodynamic, photothermal, and chemo therapies for in vivo and in vitro studies. Finally, the prospects and future challenges of UCNs in bioimaging, drug release, multimodal imaging, multi-stimuli and combinatorial responsive therapies against cancers are described. © 2022 Elsevier Inc. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Natural Sciences > Department of Chemistry > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Park, Tae Jung photo

Park, Tae Jung
자연과학대학 (화학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE